Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 9.59M $643.71M March 31, 2014
Wellington Management Company 9.13M $576.88M June 30, 2014
Vanguard 3.28M $206.97M June 30, 2014
T. Rowe Price Associates 3.25M $205.43M June 30, 2014
Franklin Resources 2.54M $160.40M June 30, 2014
Gilder, Gagnon, Howe & Co 2.00M $126.08M June 30, 2014
HealthCor Management 1.80M $16.87M June 30, 2011
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.70M $107.69M June 30, 2014
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 1.56M $98.40M June 30, 2014
HealthCor Management 1.45M $35.34M March 31, 2013
BlackRock Fund Advisors 1.41M $88.93M June 30, 2014
Bridger Management 1.37M $33.31M March 31, 2013
Deerfield Management Company 1.22M $29.77M March 31, 2013
BAILLIE GIFFORD & CO 1.19M $75.23M June 30, 2014
CITADEL ADVISORS 1.19M $36.84M June 30, 2013
Jennison Associates 1.13M $71.19M June 30, 2014
Abingworth 1.11M $20.29M Dec. 31, 2012
BlackRock Advisors 1.10M $70.19M Sept. 30, 2013
STATE STREET CORPORATION 1.07M $67.55M June 30, 2014
Wells Fargo & Company 1.01M $63.79M June 30, 2014
Columbus Circle Investors 1.00M $67.43M March 31, 2014
Falcon Edge Capital 1000000 $64.30M Dec. 31, 2013
Camber Capital Management 1000000 $31.01M June 30, 2013
MORGAN STANLEY 867619 $54.83M June 30, 2014
Capital World Investors^ 848700 $53.61M June 30, 2014
Columbia Wanger Asset Management 784500 $49.56M June 30, 2014
Renaissance Technologies 773100 $6.30M Dec. 31, 2011
NORTHERN TRUST 767144 $51.50M March 31, 2014
S.A.C. Capital Advisors 744873 $18.15M March 31, 2013
LORD, ABBETT & CO 743671 $46.98M June 30, 2014